Santa Cruz Biotechnology provides a broad selection of 8-OHdG Antibodies, essential tools for researchers studying oxidative stress and DNA damage. 8-OHdG Antibodies are compatible with various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 8-OHdG, or 8-hydroxy-2'-deoxyguanosine, is a critical biomarker for oxidative DNA damage and is often used to assess the extent of oxidative stress in cells. Elevated levels of 8-OHdG have been associated with various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, making it a significant focus in biomedical research. Understanding the role of 8-OHdG in cellular processes can provide insights into disease mechanisms and potential therapeutic targets. Research applications include monitoring oxidative stress levels in various biological samples, evaluating antioxidant effectiveness, and studying age-related cellular damage. Investigating 8-OHdG modifications helps reveal connections between oxidative stress and disease progression. The detection and quantification of 8-OHdG serve as valuable indicators for assessing cellular health and stress responses. Santa Cruz Biotechnology monoclonal antibodies for 8-OHdG research support scientists worldwide in advancing our understanding of oxidative stress-related diseases and potential treatments.